[1] L M BRALEY G H W. The effect of angiotensin II and saralasin on 18-hydroxy-11-deoxycorticosterone production by isolated human adrenal glomerulosa cells.[J]. Journal of Clinical Endocrinology & Metabolism, 1979, 49 4: 600-603. DOI:
10.1210/jcem-49-4-600[2] JOHN CARROLL James C M Pavel Komanicky. The relationship between plasma 18-hydroxy-11-deoxycorticosterone levels and production of hypertension in the rat[J]. Journal of steroid biochemistry, 1981, 14 10: Pages 989-995. DOI:
10.1016/0022-4731(81)90206-5[3] MüLLER J. The conversion of 18-hydroxycorticosterone and 18-hydroxy-11-deoxycorticosterone to aldosterone by rat adrenal tissue: Evidence for an alternative biosynthetic pathway[J]. Journal of steroid biochemistry, 1980, 13 3: Pages 245-251. DOI:
10.1016/0022-4731(80)90001-1[4] ANDRZEJ SLOMINSKI. Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells[J]. FEBS Letters, 1999, 455 3: 364-366. DOI:
10.1016/s0014-5793(99)00889-3[5] PIETER GIESBERTZ. Metabolite profiling in plasma and tissues of ob/ob and db/db mice identifies novel markers of obesity and type 2 diabetes.[J]. Diabetologia, 2015, 58 9: 2133-2143. DOI:
10.1007/s00125-015-3656-y